Paediatric neuro-Behçet’s disease: multi-centre observational study

OBJECTIVES: Behçet's disease (BD) is a multisystemic inflammatory disease, and its neurologic involvement represents serious manifestations. This study aimed to elucidate the neurologic manifestations of BD in a large paediatric population and to describe its outcomes and prognosis. METHODS: This retrospective multicentre study included 75 paediatric patients diagnosed with neuro-Behçet's disease (NBD). Demographic data, clinical features, neuroimaging findings, treatments and disability conditions were reviewed. RESULTS: Neurologic manifestations were observed in 52 patients (69.3%) at initial presentation and in 23 patients (30.7%) at a median of 14 months (8-30) after diagnosis. The distribution of NBD subgroups was as follows: 56 patients (74.7%) with nonparenchymal, 15 patients (20%) with parenchymal and 4 patients (5.3%) with mixed forms. Headache, observed in 70 patients (93.3%), was the most common neurological symptom, being significantly more frequent in the non-parenchymal form (P = 0.028). Paresis, sensory loss and mood/mental health problems were significantly more frequent in the parenchymal form (P = 0.034, P = 0.016, P = 0.005, respectively). Neuroimaging revealed parenchymal lesions in 19 patients (25.3%), and vascular lesions were in 55 patients (73.3%). Azathioprine was the most commonly used immunosuppressor therapy (78.7%). The median follow-up duration of patients was 30 months (17.5-52.5), during which significant clinical improvement was observed, with no deaths reported. CONCLUSION: Paediatric NBD remains a significant issue in paediatric rheumatology. The non-parenchymal subgroup is the predominant form in children. Paediatric NBD should be confirmed and classified by MRI. The early aggressive immunosuppressive therapy provides clinical improvement. Activity and disability indexes are valuable for treatment and follow-up.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2026-04-01
DOI
https://doi.org/10.1093/rheumatology/keag187
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Paediatric neuro-Behçet’s disease: multi-centre observational study

Taner Çoşkuner, Sema Nur Taşkın, Elif Çelikel, S. Ozen et al.
Lara D. Veeken
Ocular Diseases and Behçet’s Syndrome
article

Paediatric neuro-Behçet’s disease: multi-centre observational study

Taner Çoşkuner, Sema Nur Taşkın, Elif Çelikel, S. Ozen, Betül Sözeri, Selcan Demir, Yelda Bilginer, Mehmet Yıldız, Kübra Öztürk, Ayşe Balat, Selçuk Yüksel, Gülşah Kılbaş, E Unsal, Zahide Ekici Tekin, Nihal Şahin, Ayşenur Paç Kısaarslan, Pelin Esmeray Şenol, Merve Cansu Polat, Nilüfer Tekgöz, Yağmur Bayındır, Zehra Kızıldağ Karabacak, S. S. Kilic, Emine Nur Sunar Yayla, Özgür Kasapçopur, Zuhal Karalı, Sevcan A. Bakkaloğlu, Melisa Kacmaz, Esra Esen
article en

Abstract

OBJECTIVES: Behçet's disease (BD) is a multisystemic inflammatory disease, and its neurologic involvement represents serious manifestations. This study aimed to elucidate the neurologic manifestations of BD in a large paediatric population and to describe its outcomes and prognosis. METHODS: This retrospective multicentre study included 75 paediatric patients diagnosed with neuro-Behçet's disease (NBD). Demographic data, clinical features, neuroimaging findings, treatments and disability conditions were reviewed. RESULTS: Neurologic manifestations were observed in 52 patients (69.3%) at initial presentation and in 23 patients (30.7%) at a median of 14 months (8-30) after diagnosis. The distribution of NBD subgroups was as follows: 56 patients (74.7%) with nonparenchymal, 15 patients (20%) with parenchymal and 4 patients (5.3%) with mixed forms. Headache, observed in 70 patients (93.3%), was the most common neurological symptom, being significantly more frequent in the non-parenchymal form (P = 0.028). Paresis, sensory loss and mood/mental health problems were significantly more frequent in the parenchymal form (P = 0.034, P = 0.016, P = 0.005, respectively). Neuroimaging revealed parenchymal lesions in 19 patients (25.3%), and vascular lesions were in 55 patients (73.3%). Azathioprine was the most commonly used immunosuppressor therapy (78.7%). The median follow-up duration of patients was 30 months (17.5-52.5), during which significant clinical improvement was observed, with no deaths reported. CONCLUSION: Paediatric NBD remains a significant issue in paediatric rheumatology. The non-parenchymal subgroup is the predominant form in children. Paediatric NBD should be confirmed and classified by MRI. The early aggressive immunosuppressive therapy provides clinical improvement. Activity and disability indexes are valuable for treatment and follow-up.

Lara D. VeekenVol. 65(4)
Çanakkale Onsekiz Mart Üniversitesi (TR), Trakya University (TR), Bursa Uludağ Üni̇versi̇tesi̇ (TR), Ankara University (TR), Bilkent University (TR), Dokuz Eylül University (TR), Eskişehir City Hospital (TR), Memorial Ankara Hospital (TR), Ümraniye Eğitim ve Araştırma Hastanesi (TR), Istanbul University-Cerrahpaşa (TR), Başkent University Hospital (TR), Sağlık Bilimleri Üniversitesi (TR), Ankara Yıldırım Beyazıt University (TR), University of Health Sciences (SO), Eskişehir Osmangazi University (TR), Mersin Üniversitesi (TR), Kocaeli Üniversitesi (TR), Istanbul Medeniyet University (TR), Gaziantep University (TR), Hacettepe University (TR), Istanbul University (TR), Erciyes University (TR), Gazi University (TR)
Openalex Percentile: Top 14%
Ocular Diseases and Behçet’s Syndrome
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.